Publisher: GlobalData
Category: Diseases & Conditions

Diseases & Conditions market research reports by GlobalData

(453 reports matching your criteria)
    • Parkinson's Disease in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

      Parkinson's Disease in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 Summary This report covers the 68 geographical markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. GlobalData estima ... Read More

    • Type 1 Diabetes: 68-Market Analysis and Sales Forecast

      Type 1 Diabetes: 68-Market Analysis and Sales Forecast Summary This report covers the 68 geographical markets and provides an Excel-based forecast model for the type 1 diabetes market from 2023-2033. This publication is an expanded version of the Excel model containing the patient-based forecast (PB ... Read More

    • Malaysia - The Future of Foodservice to 2028

      Malaysia - The Future of Foodservice to 2028 Summary The foodservice profit sector generated a revenue of MYR93.2 billion ($20.4 billion) in 2023, rising at a CAGR of 1.5% during 2018-23. As tourism grew and consumers reverted to pre-pandemic lifestyles, foodservice sales grew. The number of transac ... Read More

    • Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis

      Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis Summary This report covers the 8 major markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 ... Read More

    • Alzheimer’s Disease: 68-Market Analysis and Sales Forecast

      Alzheimer’s Disease: 68-Market Analysis and Sales Forecast Summary This report covers the 68 geographical markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 ... Read More

    • Tourette Syndrome - Global Clinical Trials Review, 2024

      Tourette Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Tourette Syndrome - Global Clinical Trials Review, 2024 provides an overview of Tourette Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Toure ... Read More

    • Aplastic Anemia - Global Clinical Trials Review, 2024

      Aplastic Anemia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Aplastic Anemia - Global Clinical Trials Review, 2024 provides an overview of Aplastic Anemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic An ... Read More

    • Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024

      Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024 provides an overview of Crohn's Disease (Regional Enteritis) Clinical trials scenario. This report provid ... Read More

    • Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024

      Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024 provides an overview of Bile Duct Cancer (Cholangiocarcinoma) Clinical trials scenario. This report pro ... Read More

    • Obstructive Sleep Apnea - Global Clinical Trials Review, 2024

      Obstructive Sleep Apnea - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Obstructive Sleep Apnea - Global Clinical Trials Review, 2024 provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

    • Innovation Insights: Anti-sense Oligonucleotides

      Innovation Insights: Anti-sense Oligonucleotides Summary Antisense oligonucleotides (ASOs) are short, synthetic strands of DNA or RNA designed to bind to specific mRNA sequences, thereby modulating gene expression. They work through mechanisms such as RNase H-mediated degradation, steric blocking, a ... Read More

    • Innovation Insights: B-cell Depletion

      Innovation Insights: B-cell Depletion Summary B cell depletion is a therapeutic strategy aimed at reducing the number of B lymphocytes, which play a crucial role in autoimmune diseases and certain cancers. This approach is primarily used to treat conditions like rheumatoid arthritis, multiple sclero ... Read More

    • Hepatitis C Therapeutics: Competitive Landscape

      Hepatitis C Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis C Therapeutics . GlobalData epidemiologists estimate that there will be 25.16 million diagnosed prevalent cases of Hepatitis C (HCV) infec ... Read More

    • Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Glucose Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, ... Read More

    • Key Trends in Car Rental (2024)

      Key Trends in Car Rental (2024) Summary GlobalData’s Key Trends in Car Rental (2024) report provides in-depth analysis of the key market trends that are shaping the future of this segment. It includes analysis of key market trends, leading companies, sector deals, challenges and opportunities. Scope ... Read More

    • Refractory Multiple Myeloma - Global Clinical Trials Review, 2024

      Refractory Multiple Myeloma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Refractory Multiple Myeloma - Global Clinical Trials Review, 2024 provides an overview of Refractory Multiple Myeloma Clinical trials scenario. This report provides top line data relating t ... Read More

    • Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024

      Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024 provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of ... Read More

    • Dengue Fever - Global Clinical Trials Review, 2024

      Dengue Fever - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dengue Fever - Global Clinical Trials Review, 2024 provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report ... Read More

    • Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024

      Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024 provides an overview of Relapsed Multiple Myeloma Clinical trials scenario. This report provides top line data relating to the ... Read More

    • Burkitt Lymphoma - Global Clinical Trials Review, 2024

      Burkitt Lymphoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Burkitt Lymphoma - Global Clinical Trials Review, 2024 provides an overview of Burkitt Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt ... Read More

    • Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More

    • Hepatitis B Therapeutics: Competitive Landscape

      Hepatitis B Therapeutics: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hepatitis B Therapeutics . GlobalData epidemiologists estimate that there will be 21.91 million diagnosed prevalent cases of HBV in 2024, which is e ... Read More

    • Diabetic Retinopathy - Global Clinical Trials Review, 2024

      Diabetic Retinopathy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Diabetic Retinopathy - Global Clinical Trials Review, 2024 provides an overview of Diabetic Retinopathy Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More

    • Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024

      Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024 provides an overview of Herpes Zoster (Shingles) Clinical trials scenario. This report provides top line data relating to the cli ... Read More

    • Czech Republic Telecom Operators Country Intelligence Report

      Czech Republic Telecom Operators Country Intelligence Report Summary Czech Republic Telecom Operators Country Intelligence Report, a new Country Intelligence Report by GlobalData, provides an executive-level overview of the telecommunications market in Czech Republic today, with detailed forecasts o ... Read More

1 2 3 4 5 6 7 8 9 10

Cookie Settings